Xarelto lawsuits continue to mount in the federal multidistrict litigation now underway in the U.S. District Court, Eastern District of Louisiana. A newly-released MDL Statistic Report indicates that at least 14,935 cases were pending in the proceeding as of January 17th, an increase of 470 filings over the previous month.

One of the more recent claims to join the docket was filed on behalf of a Louisiana woman who allegedly died last year due to serious Xarelto side effects, including uncontrollable bleeding, anemia, sepsis and kidney failure. Like other plaintiffs involved in the litigation, the decedent’s children assert that the manufacturers of Xarelto concealed important safety information and showed a “callous, reckless, willful, depraved indifference to the health, safety and welfare” of patients like their mother.

Xarelto was approved by the U.S. Food & Drug Administration in October 2011. By the end of the following fiscal year, more  than 2,000 Xarelto-related adverse events had been filed with the agency. Of these, 151 resulted in the death of the patient. Xarelto plaintiffs claim that the drug was wrongly marketed as an improvement over warfarin, an anticoagulant that has been on the market for decades. They point out that the internal bleeding sometimes associated with warfarin use can be reversed via the administration of vitamin K. However, there is currently no approved antidote for similar Xarelto bleeding.

Xarelto Bellwether Trials

The federal Xarelto litigation is scheduled to convene a series of bellwether trials this year, with the first case set to begin in March. The Xarelto lawsuit selected for the first trial was filed on behalf of another Louisiana resident who suffered a dangerous episode of gastrointestinal bleeding in 2014, just a month after he began taking the blood thinner for atrial fibrillation.

A fourth trial is scheduled to begin in late April, while a third case will head to a jury the following month. Verdicts in these trials are expected to yield some insight into how juries might rule in similar Xarelto bleeding claims.

Bernstein Liebhard LLP continues to investigate Xarelto injury claims. If you or a loved one experienced a dangerous, bleeding-related adverse event while using this medication, please call 877-779-1414 to learn more about your legal right.

Published January 23, 2017 by